Loading clinical trials...
Loading clinical trials...
Early (4th Week) Versus Late (6thweek) Interval Postpartum Copper Intrauterine Device Insertion: a Randomized Controlled Trial
The optimal interval between pregnancies is debated, but a duration greater than 11-18 months has been suggested as reducing complications in the subsequent pregnancy. Improved birth spacing can be a key benefit use of long-acting reversible contraception, but delay to initiation can still be problematic.So women who have recently given birth can be cost-effectively targeted for family planning education and engagement because often they are already connected with health professionals
Age
20 - 40 years
Sex
FEMALE
Healthy Volunteers
No
Assiut Faculty of Medicine
Asyut, Egypt
Start Date
July 1, 2017
Primary Completion Date
November 1, 2021
Completion Date
March 1, 2022
Last Updated
May 11, 2022
early insertion
PROCEDURE
late insertion
PROCEDURE
Lead Sponsor
Assiut University
NCT06943209
NCT06579781
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06100679